MEDGF(MEDGF)
MEDGF
No analyst ratings available
No analyst price targets available for MEDGF
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $758M | $851M | $946M | $1.06B |
| Low | $737M | $827M | $919M | $1.03B |
| High | $774M | $869M | $966M | $1.08B |
| EBITDA Avg | $225M | $253M | $281M | $315M |
| Low | $219M | $246M | $273M | $306M |
| High | $230M | $258M | $287M | $321M |
| EBIT Avg | $125M | $140M | $156M | $174M |
| Low | $121M | $136M | $151M | $169M |
| High | $127M | $143M | $159M | $178M |
| Net Income Avg | $103M | $117M | $138M | $169M |
| Low | $99M | $113M | $133M | $163M |
| High | $106M | $120M | $142M | $173M |
| EPS Avg | $5.16 | $5.86 | $6.92 | $8.43 |
| Low | $4.97 | $5.65 | $6.67 | $8.13 |
| High | $5.30 | $6.02 | $7.11 | $8.67 |
| Analysts (Rev / EPS) | 6 / 1 | 3 / 1 | 2 / 1 | 5 / 1 |